0001209191-24-003423.txt : 20240215
0001209191-24-003423.hdr.sgml : 20240215
20240215203842
ACCESSION NUMBER: 0001209191-24-003423
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novo Holdings A/S
CENTRAL INDEX KEY: 0001388325
ORGANIZATION NAME:
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41949
FILM NUMBER: 24645547
BUSINESS ADDRESS:
STREET 1: TUBORG HAVNEVEJ 19
CITY: HELLERUP
STATE: G7
ZIP: 2900
BUSINESS PHONE: 45 8824 8824
MAIL ADDRESS:
STREET 1: TUBORG HAVNEVEJ 19
CITY: HELLERUP
STATE: G7
ZIP: 2900
FORMER NAME:
FORMER CONFORMED NAME: Novo A/S
DATE OF NAME CHANGE: 20070130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Metagenomi, Inc.
CENTRAL INDEX KEY: 0001785279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813909017
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET
STREET 2: 7TH FLOOR
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-4880
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET
STREET 2: 7TH FLOOR
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: Metagenomi Technologies, LLC
DATE OF NAME CHANGE: 20190812
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-09
1
0001785279
Metagenomi, Inc.
MGX
0001388325
Novo Holdings A/S
TUBORG HAVNEVEJ 19
HELLERUP
G7
2900
DENMARK
0
0
1
0
0
COMMON STOCK
2024-02-09
4
P
0
100000
10.25
A
100000
D
COMMON STOCK
2024-02-13
4
C
0
839175
A
939175
D
COMMON STOCK
2024-02-13
4
P
0
800000
15.00
A
1739175
D
SERIES B PREFERRED STOCK
2024-02-13
4
C
0
147415
D
COMMON STOCK
147415
0
D
SERIES B-1 PREFERRED STOCK
2024-02-13
4
C
0
691760
D
COMMON STOCK
691760
0
D
Each share of Series B Preferred Stock and Series B-1 Preferred Stock converted into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date.
Represents a purchase from the underwriters in the Issuer's initial public offering.
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations
2024-02-15